Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • ACE2 receptor

Tag: ACE2 receptor

  • Biotechnopedia
  • DNA-Tales

Neurological Effects in COVID-19 Patients

DNA tales August 9, 2021August 9, 2021

Aayushi Gaur, U. I. E. T., Kurukshetra University Doctors battled to keep patients breathing in the early months of the COVID-19 pandemic, focusing mostly on treating lung and circulatory system damage. However, evidence of neurological consequences was already collecting at the time. Some COVID-19 patients were suffering from delirium, which manifested as confusion, disorientation, and […]

Read More
  • BiotechToday
  • World

O-glycosylation on SARS-CoV-2: Emergence of Model D

BioTech Today July 28, 2021July 27, 2021

Saptaparna Dasgupta, Bennett University SARS-CoV-2, a strain from the Coronavirus family, is responsible for the ongoing global pandemic of COVID-19, taking the lives of millions of people via an infectious respiratory illness. Several studies have been conducted on this virus to find target proteins responsible for the infection as a therapeutic. Thus, spike (S) protein […]

Read More
  • BiotechToday
  • World

Hypertension cause hyper-inflammation and delays viral clearance for COVID-19 patients

bioxone December 30, 2020December 30, 2020 1

Devyani Goswami, Amity University Kolkata Hypertension and cardiovascular diseases are considered as vital risk factors for critical disease progression for COVID-19 contracted patients. 1 out of every 5 individual suffers from hypertension. Hypertension is observed to develop serious problems in the later stage of the infection, as these patients are more likely to develop pneumonia […]

Read More
  • Biotechnopedia
  • DNA-Tales

Role of Angiotensin receptor blockers towards COVID-19

bioxone September 27, 2020September 27, 2020

Debraj Ghosh, Undergraduate student of Medicinal Institute, People’s Friendship Institute of Russia, Moscow, Russia Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(1) is the strain of coronavirus causes the respiratory illness responsible for the COVID-19 pandemic. It is a positive ssRNA(4) virus that is contagious to humans and is a successor to SARS-CoV-1 according to the U.S. National Institute of Health. The SARS-CoV-2 virion […]

Read More
  • India

COVID UPDATE: Indian genes against the coronavirus

bioxone September 18, 2020September 18, 2020

-Binayak Das, Team bioXone A team of scientists claims that Indians should be grateful to their genetics, which according to their study is a critical factor in having a comparatively lesser number of deaths from COVID-19 in their populations. They studied the complete DNA data of the ACE2 gene in the X chromosomes from different […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COMPUTER DESIGNED SYNTHETIC ANTIVIRAL PROTEINS INHIBIT SARS-COV 2/COVID 19 IN HUMAN CELLS

bioxone September 15, 2020September 15, 2020

–Rishav Chakraborty, Calcutta National Medical College, Kolkata The SARS-COV infection occurred first in 2003-2004. The infection is believed to be contracted from animals including monkeys, Himalayan palm civets, cats, dogs, and rodents. Clinical manifestation including myalgia, headache, sore throat, and fever followed by severe respiratory distress. The virus binds with the ACE-2 (Angiotensinogen Converting Enzyme) […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy